Cargando…
Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD
Nonalcoholic fatty liver disease (NAFLD) is associated with obesity but also found in non-obese individuals. Gut microbiome profiles of 171 Asians with biopsy-proven NAFLD and 31 non-NAFLD controls are analyzed using 16S rRNA sequencing; an independent Western cohort is used for external validation....
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536225/ https://www.ncbi.nlm.nih.gov/pubmed/33020474 http://dx.doi.org/10.1038/s41467-020-18754-5 |
_version_ | 1783590519715135488 |
---|---|
author | Lee, Giljae You, Hyun Ju Bajaj, Jasmohan S. Joo, Sae Kyung Yu, Junsun Park, Seoyeon Kang, Hyena Park, Jeong Hwan Kim, Jung Ho Lee, Dong Hyeon Lee, Seonhwa Kim, Won Ko, GwangPyo |
author_facet | Lee, Giljae You, Hyun Ju Bajaj, Jasmohan S. Joo, Sae Kyung Yu, Junsun Park, Seoyeon Kang, Hyena Park, Jeong Hwan Kim, Jung Ho Lee, Dong Hyeon Lee, Seonhwa Kim, Won Ko, GwangPyo |
author_sort | Lee, Giljae |
collection | PubMed |
description | Nonalcoholic fatty liver disease (NAFLD) is associated with obesity but also found in non-obese individuals. Gut microbiome profiles of 171 Asians with biopsy-proven NAFLD and 31 non-NAFLD controls are analyzed using 16S rRNA sequencing; an independent Western cohort is used for external validation. Subjects are classified into three subgroups according to histological spectra of NAFLD or fibrosis severity. Significant alterations in microbiome diversity are observed according to fibrosis severity in non-obese, but not obese, subjects. Ruminococcaceae and Veillonellaceae are the main microbiota associated with fibrosis severity in non-obese subjects. Furthermore, stool bile acids and propionate are elevated, especially in non-obese subjects with significant fibrosis. Fibrosis-related Ruminococcaceae and Veillonellaceae species undergo metagenome sequencing, and four representative species are administered in three mouse NAFLD models to evaluate their effects on liver damage. This study provides the evidence for the role of the microbiome in the liver fibrosis pathogenesis, especially in non-obese subjects. |
format | Online Article Text |
id | pubmed-7536225 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-75362252020-10-19 Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD Lee, Giljae You, Hyun Ju Bajaj, Jasmohan S. Joo, Sae Kyung Yu, Junsun Park, Seoyeon Kang, Hyena Park, Jeong Hwan Kim, Jung Ho Lee, Dong Hyeon Lee, Seonhwa Kim, Won Ko, GwangPyo Nat Commun Article Nonalcoholic fatty liver disease (NAFLD) is associated with obesity but also found in non-obese individuals. Gut microbiome profiles of 171 Asians with biopsy-proven NAFLD and 31 non-NAFLD controls are analyzed using 16S rRNA sequencing; an independent Western cohort is used for external validation. Subjects are classified into three subgroups according to histological spectra of NAFLD or fibrosis severity. Significant alterations in microbiome diversity are observed according to fibrosis severity in non-obese, but not obese, subjects. Ruminococcaceae and Veillonellaceae are the main microbiota associated with fibrosis severity in non-obese subjects. Furthermore, stool bile acids and propionate are elevated, especially in non-obese subjects with significant fibrosis. Fibrosis-related Ruminococcaceae and Veillonellaceae species undergo metagenome sequencing, and four representative species are administered in three mouse NAFLD models to evaluate their effects on liver damage. This study provides the evidence for the role of the microbiome in the liver fibrosis pathogenesis, especially in non-obese subjects. Nature Publishing Group UK 2020-10-05 /pmc/articles/PMC7536225/ /pubmed/33020474 http://dx.doi.org/10.1038/s41467-020-18754-5 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Lee, Giljae You, Hyun Ju Bajaj, Jasmohan S. Joo, Sae Kyung Yu, Junsun Park, Seoyeon Kang, Hyena Park, Jeong Hwan Kim, Jung Ho Lee, Dong Hyeon Lee, Seonhwa Kim, Won Ko, GwangPyo Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD |
title | Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD |
title_full | Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD |
title_fullStr | Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD |
title_full_unstemmed | Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD |
title_short | Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD |
title_sort | distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese nafld |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536225/ https://www.ncbi.nlm.nih.gov/pubmed/33020474 http://dx.doi.org/10.1038/s41467-020-18754-5 |
work_keys_str_mv | AT leegiljae distinctsignaturesofgutmicrobiomeandmetabolitesassociatedwithsignificantfibrosisinnonobesenafld AT youhyunju distinctsignaturesofgutmicrobiomeandmetabolitesassociatedwithsignificantfibrosisinnonobesenafld AT bajajjasmohans distinctsignaturesofgutmicrobiomeandmetabolitesassociatedwithsignificantfibrosisinnonobesenafld AT joosaekyung distinctsignaturesofgutmicrobiomeandmetabolitesassociatedwithsignificantfibrosisinnonobesenafld AT yujunsun distinctsignaturesofgutmicrobiomeandmetabolitesassociatedwithsignificantfibrosisinnonobesenafld AT parkseoyeon distinctsignaturesofgutmicrobiomeandmetabolitesassociatedwithsignificantfibrosisinnonobesenafld AT kanghyena distinctsignaturesofgutmicrobiomeandmetabolitesassociatedwithsignificantfibrosisinnonobesenafld AT parkjeonghwan distinctsignaturesofgutmicrobiomeandmetabolitesassociatedwithsignificantfibrosisinnonobesenafld AT kimjungho distinctsignaturesofgutmicrobiomeandmetabolitesassociatedwithsignificantfibrosisinnonobesenafld AT leedonghyeon distinctsignaturesofgutmicrobiomeandmetabolitesassociatedwithsignificantfibrosisinnonobesenafld AT leeseonhwa distinctsignaturesofgutmicrobiomeandmetabolitesassociatedwithsignificantfibrosisinnonobesenafld AT kimwon distinctsignaturesofgutmicrobiomeandmetabolitesassociatedwithsignificantfibrosisinnonobesenafld AT kogwangpyo distinctsignaturesofgutmicrobiomeandmetabolitesassociatedwithsignificantfibrosisinnonobesenafld |